M. Clements

发表

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

P. Schellhammer, Y. Yasui, B. Adam, 2002, Cancer research.

Data Reduction Using a Discrete Wavelet Transform in Discriminant Analysis of Very High Dimensionality Data

P. Schellhammer, J. Potter, Y. Yasui, 2003, Biometrics.

Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.

Mary Ann Comunale, P. Schellhammer, M. Clements, 2009, Journal of proteome research.

Serum levels of endothelial and neural cell adhesion molecules in prostate cancer

P. Schellhammer, George L. Wright, M. Clements, 1997, The Prostate.

Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease.

P. Schellhammer, E. Dalmasso, B. Adam, 2001, Cancer research.

Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease.

M. Clements, J. Nyalwidhe, R. Drake, 2009, Journal of proteomics.

Development and Clinical Evaluation of a Recombinant-Antigen-Based Cytomegalovirus Immunoglobulin M Automated Immunoassay Using the Abbott AxSYM Analyzer

George L. Wright, M. Clements, T. Lazzarotto, 2000, Journal of Clinical Microbiology.

Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue

Lisa H Cazares, S. Mendrinos, M. Clements, 2009, Clinical Cancer Research.

Hyperplasia and Healthy Men ProstateAlgorithm Distinguishes Prostate Cancer from Benign Serum Protein Fingerprinting Coupled with a Pattern-matching Updated

P. Schellhammer, Y. Yasui, B. Adam, 2002 .

Deoxyribonucleic acid cytometric analysis of prostate core biopsy specimens: relationship to serum prostate specific antigen and prostatic acid phosphatase, clinical stage and histopathology.

P. Schellhammer, M. Clements, P. Kolm, 1993, The Journal of urology.

Advances in Brief Quantitation of Serum Prostate-specific Membrane Antigen by a Novel Protein Biochip Immunoassay Discriminates Benign from Malignant Prostate Disease 1

P. Schellhammer, E. Dalmasso, B. Adam, 2001 .